FDA Formally Accepts Dilon’s MarginProbe® System Pre-Market Approval (PMA) Application and Grants Expedited Review Status

By DAY Vision | May 16, 2011

[vc_row][vc_column][vc_column_text]FRAMINGHAM, MA, May 16, 2011 – Dilon Devices, Inc. today announced that the U.S. Food and Drug Administration (FDA) formally accepted for filing the company’s Pre-Market Approval (PMA) application for the MarginProbe™ System. The FDA’s actions mean that the PMA application was sufficiently complete and ready for substantive review. Additionally, the FDA believes MarginProbe represents…

Read More